HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.

HOLX nears its 52-week high on diagnostics growth and AI adoption, while tariffs and challenges in China continue to pose risks.

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...

Hologic trades at a forward one-year price-to-sales (P/S) of 3.86X, higher than its median. In contrast, Labcorp’s forward ...

Buyout marks the largest medical devices deal since 2006 Private equity firms capitalize on undervalued healthcare assets Improving credit markets enabling larger buyouts The buyout shows how the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After rumors swirled for months ...

Blackstone and TPG are buying Hologic for up to $18.3 billion, including debt. Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding Hologic shares for $76 apiece in cash, ...

Private equity firms Blackstone and TPG will spend more than $13 billion to buy women’s health specialist Hologic. The companies said Tuesday they will pay up to $79 for each Hologic share in a deal ...

(Reuters) -Private equity firms Blackstone and TPG on Tuesday said they will buy medical diagnostics firm Hologic for $18.3 billion including debt, in the largest medical devices deal in almost two ...

Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic’s Closing ...

The transaction includes significant minority investments from Abu Dhabi Investment Authority and GIC The agreement is expected to close in the first half of calendar year 2026 Blackstone and TPG have ...